VanEck Semiconductor ETF vs UnitedHealth Group Inc — how do they compare? VanEck Semiconductor ETF trades at $584, while UnitedHealth Group Inc trades at $436 (market cap $382.83B). The key difference: UnitedHealth Group Inc pays a 2.2% dividend while VanEck Semiconductor ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, VanEck Semiconductor ETF nearer its low. Which is the better fit depends on your goals.
| SMH | UNH | |
|---|---|---|
52-Week High | $668.91 | $431.68 |
52-Week Low | $283.95 | $237.77 |
Market Cap | — | $382.83B |
Sector | — | Health |
Enterprise Value | — | $429.52B |
Dividend Yield | — | 2.2% |
Signals from Pluang's Aura AI — not financial advice
SMH trades at $584.08, up 5.08% in the last 24 hours, but technical indicators signal a bearish trend with moving averages showing strong selling pressure. The semiconductor ETF faces mixed sentiment as AI-driven chip stocks correct despite strong Q2 earnings. Recent institutional buying by firms like Empirical Wealth Management and Assetmark Inc. contrasts with broader market concerns about semiconductor sector rotation and China's potential export controls on AI technologies.
Near-term outlook remains cautious due to technical bearish signals and sector volatility, though oversold RSI levels suggest potential for a rebound. Key risks include geopolitical tensions, AI capex slowdown fears, and concentrated portfolio exposure. The ETF's performance hinges on semiconductor earnings momentum and hyperscaler spending trends through 2027.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $6.38 surpassing expectations of $4.94. Revenue growth remains robust, reaching $447.57 billion in 2025, though net margins have compressed to 2.68%. Recent corporate actions include a $2.32 dividend and ongoing share repurchases, while news highlights operational streamlining like reduced pediatric prior authorizations.
UNH's outlook is positive, driven by aging demographics and tech innovation in healthcare, offering upside to the $467.12 consensus target. Risks include regulatory scrutiny, as seen in Massachusetts' Medicaid lawsuit, and margin pressure from rising costs. Institutional sentiment is strongly bullish, with 82.69% of analysts rating it a buy, supporting long-term growth prospects amid sector tailwinds.
Trailing returns across standard periods
Latest headlines on both assets
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →